Profile data is unavailable for this security.
About the company
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. The Company has two wholly owned subsidiaries, including NervGen US Inc. and NervGen Australia Pty Ltd.
- Revenue in CAD (TTM)0.00
- Net income in CAD-20.02m
- Incorporated2017
- Employees10.00
- LocationNervGen Pharma Corp112-970 Burrard Street, Unit 1290VANCOUVER V6Z 2R4CanadaCAN
- Phone+1 (778) 731-1711
- Fax+1 (604) 722-5361
- Websitehttps://www.nervgen.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arch Biopartners Inc | 1.85m | -1.95m | 106.63m | -- | -- | -- | -- | 57.73 | -0.0312 | -0.0312 | 0.0296 | -0.091 | 2.73 | -- | 4.38 | -- | -288.23 | -214.82 | -- | -- | -- | -- | -105.69 | -180.45 | -- | -3.94 | -- | -- | 105.63 | -- | -136.30 | -- | -- | -- |
| Biosyent Inc | 32.84m | 7.05m | 106.70m | 0.00 | 15.45 | 3.04 | 14.20 | 3.25 | 0.5856 | 0.5856 | 2.72 | 2.97 | 0.8341 | 1.23 | 10.80 | -- | 17.92 | 14.77 | 20.00 | 16.92 | 80.41 | 79.74 | 21.48 | 19.99 | 6.37 | -- | 0.0329 | 9.26 | 13.12 | 7.97 | 18.35 | 2.52 | -2.67 | -- |
| Oncolytics Biotech Inc | 0.00 | -28.21m | 110.11m | 29.00 | -- | 4.79 | -- | -- | -0.4027 | -0.4027 | 0.00 | 0.3046 | 0.00 | -- | -- | -- | -80.51 | -81.99 | -88.84 | -97.25 | -- | -- | -- | -- | -- | -- | 0.0468 | -- | -- | -- | -11.75 | -- | -40.52 | -- |
| Sernova Corp | 0.00 | -40.73m | 112.26m | -- | -- | 29.27 | -- | -- | -0.1343 | -0.1343 | 0.00 | 0.0126 | 0.00 | -- | -- | -- | -124.29 | -74.84 | -180.95 | -85.03 | -- | -- | -- | -- | -- | -- | 0.142 | -- | -- | -- | -59.69 | -- | -2.91 | -- |
| Eupraxia Pharmaceuticals Inc | 0.00 | -41.69m | 130.02m | 29.00 | -- | 4.88 | -- | -- | -1.65 | -1.65 | 0.00 | 0.7476 | 0.00 | -- | -- | 0.00 | -122.29 | -127.84 | -185.74 | -935.99 | -- | -- | -- | -- | -- | -85.63 | 0.3455 | -- | -- | -- | -52.63 | -- | -7.69 | -- |
| NervGen Pharma Corp | 0.00 | -20.02m | 136.36m | 10.00 | -- | 7.24 | -- | -- | -0.3363 | -0.3363 | 0.00 | 0.2692 | 0.00 | -- | -- | -- | -78.68 | -121.15 | -138.24 | -180.20 | -- | -- | -- | -- | -- | -9.07 | 0.0092 | -- | -- | -- | -8.01 | -- | 2.20 | -- |
| Spectral Medical Inc | 1.74m | -17.93m | 136.97m | 29.00 | -- | -- | -- | 78.90 | -0.0643 | -0.0647 | 0.0062 | -0.0721 | 0.2507 | 3.23 | 2.19 | 59,862.07 | -258.89 | -109.65 | -18,581.35 | -175.35 | 37.85 | 63.74 | -1,032.89 | -445.72 | 0.3287 | -2.56 | -- | -- | -4.14 | -16.08 | -104.12 | -- | 31.53 | -- |
| Zentek Ltd | 33.61k | -11.98m | 151.23m | 27.00 | -- | 6.73 | -- | 4,499.54 | -0.1197 | -0.1197 | 0.0003 | 0.2228 | 0.0013 | 0.0796 | 0.0876 | 1,244.82 | -44.53 | -41.94 | -48.53 | -44.46 | -573.70 | -- | -35,636.60 | -12,771.31 | 4.27 | -- | 0.0538 | -- | -79.01 | -- | 54.52 | -- | 39.27 | -- |
